These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24145957)

  • 1. Identification of inflammatory neuronal injury and prevention of neuronal damage in multiple sclerosis: hope for novel therapies?
    Zipp F; Gold R; Wiendl H
    JAMA Neurol; 2013 Dec; 70(12):1569-74. PubMed ID: 24145957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.
    Ellwardt E; Zipp F
    Exp Neurol; 2014 Dec; 262 Pt A():8-17. PubMed ID: 24530639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy.
    Lassmann H
    J Neurol Sci; 2011 Jul; 306(1-2):167-9. PubMed ID: 20719338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets.
    Aktas O; Waiczies S; Zipp F
    J Neuroimmunol; 2007 Mar; 184(1-2):17-26. PubMed ID: 17222462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.
    Vigeveno RM; Wiebenga OT; Wattjes MP; Geurts JJ; Barkhof F
    J Magn Reson Imaging; 2012 Jul; 36(1):1-19. PubMed ID: 22696123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in multiple sclerosis: novel treatment strategies.
    Luessi F; Siffrin V; Zipp F
    Expert Rev Neurother; 2012 Sep; 12(9):1061-76; quiz 1077. PubMed ID: 23039386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration and -protection in autoimmune CNS inflammation.
    Diem R; Sättler MB; Bähr M
    J Neuroimmunol; 2007 Mar; 184(1-2):27-36. PubMed ID: 17188756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated neurodegeneration and neuroprotection in MS.
    Giuliani F; Yong VW
    Int MS J; 2003 Dec; 10(4):122-30. PubMed ID: 14977489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory demyelination and neurodegeneration in early multiple sclerosis.
    Charil A; Filippi M
    J Neurol Sci; 2007 Aug; 259(1-2):7-15. PubMed ID: 17397873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.
    Zipp F
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S24-9. PubMed ID: 20106345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New directions in MS therapeutics: vehicles of hope.
    Fox RJ; Ransohoff RM
    Trends Immunol; 2004 Dec; 25(12):632-6. PubMed ID: 15530830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL; Oksenberg JR
    Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
    Stroet A; Linker RA; Gold R
    J Neural Transm (Vienna); 2013 Sep; 120 Suppl 1():S49-53. PubMed ID: 23720188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy in multiple sclerosis.
    Milo R; Panitch H
    J Neuroimmunol; 2011 Feb; 231(1-2):23-31. PubMed ID: 21111490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
    Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancement of therapies for neuroprotection in multiple sclerosis.
    Lo A
    Expert Rev Neurother; 2008 Sep; 8(9):1355-66. PubMed ID: 18759548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.